The Effects of ESP Block and Mid-Transverse Process to Pleura Block on Postoperative Opioid Consumption and Quality of Recovery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorAydin Adnan Menderes University

About this trial

Erector Spinae Area (ESP) Block and Mid-Transverse Process to Pleura Block(MTP) have recently been described for the treatment of pain after lumbar spinal surgery. Although these blocks have been shown to be effective in the treatment of pain after lumbar spinal surgery when compared with postoperative pain, they have not been compared in terms of the quality of recovery and opioid consumption after lumbar spinal surgery.

The aim of this clinical trial is to compare the effects of Erector Spinae Area (ESP) Block and Mid-Transverse Process to Pleura Block(MTP) on quality of recovery and opioid consumption in patients scheduled for lumbar spinal surgery. The effects of the 2 blocks on postoperative pain will also be compared and recorded.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Elective Lumbar Spinal surgery performed

ASA I-III

18-75 years old

Disqualifiers

Refusal at enrollment

Request for withdrawal from the study

Inability to give informed consent

Emergency surgery

Trial design

Design model

Parallel

Treatments tested in this trial

  • Numeretic rating scale (NRS)

    Diagnostic test

    NRS is a pain intensity determination system based on the person being asked to describe their pain on a scale of 0 (none), 10 (unbearable pain) and a point between.

  • Quality of Results (QoR-40)

    Diagnostic test

    Several rating scales have been developed to measure quality of recovery after surgery and anaesthesia, but the most extensively used is the QoR-40, a 40-item questionnaire that provides a global score and subscores across five dimensions: patient support, comfort, emotions, physical independence, and pain.

  • Opioid consuption

    Other intervention

    Opioid consuption will be recorded from PCA

Treatment groups

126 Participants
are divided into 2 treatment groups
Group A: esp blockActive comparator 3 interventions
Group B: mtp blockExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

postoperative opioid consumption

The patient will be administered tramadol PCA every eight hours and recorded.

Time frame
PCA results will be recorded at the 1st, 6th, 12th, 24th hours postoperatively.

Secondary outcomes

1

quality of recovery

The quality of recovery (QoR-40) of patients who underwent both ESP block and MTP block at the 24th hour postoperatively will be evaluated with a scoring system.

Time frame
24 hours

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: